BioCentury
ARTICLE | Company News

Enzon, SGP get European marketing approval

March 28, 2001 8:00 AM UTC

ENZN partner Schering-Plough (SGP) received European marketing authorization for Pegintron peginterferon alfa-2b in combination with SGP's Rebetol ribavirin capsules as a combination therapy to treat ...